Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial
Specific measures like safety, effectiveness, and dosing for AUD still need to be tested and confirmed
Compounders were supposed to cease manufacturing their versions in the months after, but many have continued, buoyed by the consumer-driven market and the vast network of options that essentially have the agency playing whack-a-mole.
Research shows that GLP-1 receptors are found in several organs, including the pancreas, heart, and kidneys, which means GLP-1RAs have broad pharmacological effects
This study does, however, have limitations typical of real-world data and we recognise the early exploratory nature of our work would benefit from further dedicated longitudinal studies with more robust design methodology in order to confirm our findings
Hyperhidrosis and Its Impact on Those Living With It